Long-term COVID-19 sequelae by Theta and SARS-CoV-2 variants in a Philippine cohort.
Saloma, Cynthia P, Ayes, Marc Edsel C, Taracatac, Paolo S et al. · Frontiers in medicine · 2024 · DOI
Quick Summary
This study followed people in the Philippines who had COVID-19 to see how long their symptoms lasted and whether different COVID variants caused different long-term problems. Researchers checked in with patients three times over a year and found that most people (68-88%) still had symptoms months after infection, with fatigue, brain fog, and headaches being the most common. The good news was that symptoms generally improved over time, though many people continued to struggle with debilitating effects.
Why It Matters
This study documents that Long COVID affects a large proportion of people across different SARS-CoV-2 variants and persists for at least a year, supporting the need for healthcare systems to recognize and support long-term COVID sequelae—a concern that parallels ME/CFS recognition challenges. The identification of post-exertional malaise as a cardinal symptom strengthens connections between Long COVID and ME/CFS pathophysiology, emphasizing the importance of monitoring and accommodating exertional intolerance in both conditions.
Observed Findings
Long COVID symptom prevalence was 88% at initial assessment (S1), declining to 82% at second assessment (S2) and 68% at third assessment (S3)—showing gradual improvement over 12 months.
Fatigue, headache, and intermittent brain fog were the most frequently reported symptoms across all three data collection points and across all SARS-CoV-2 variant groups.
Neuropsychiatric symptoms were the second most common category of Long COVID manifestations reported.
Age, sex, comorbidities, and initial disease severity significantly influenced the frequency of reported symptoms.
Symptom burden remained heterogeneous, with no single symptom profile common to all affected individuals.
Inferred Conclusions
A majority of people infected with SARS-CoV-2 (>68%) experience long-term sequelae characterized by diverse, debilitating symptoms that persist for at least 12 months post-infection.
Post-exertional malaise, fatigue, and cognitive dysfunction are core features of Long COVID across different viral variants, suggesting shared pathophysiological mechanisms.
Long-term monitoring and targeted health system responses are necessary to address the substantial disease burden of Long COVID in the population.
Remaining Questions
Do the identified risk factors (age, sex, comorbidities, disease severity) have different predictive values across distinct viral variants, or do they operate similarly regardless of variant exposure?
What This Study Does Not Prove
This study does not establish causation between specific variants and distinct symptom profiles, nor does it clarify whether symptom improvement reflects true recovery or adaptation. It cannot determine whether observed symptoms meet formal ME/CFS diagnostic criteria, and without a control group (non-infected or mildly infected individuals), it does not establish that reported symptoms are unique to COVID-19 infection rather than attributable to concurrent conditions or confounders.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What mechanisms underlie the gradual symptom improvement from S1 to S3, and does this reflect true pathophysiological recovery or accommodation/habituation in reporting?
How do Long COVID symptom profiles compare to ME/CFS diagnostic criteria, and what proportion of Long COVID cases would meet ME/CFS case definitions if formally assessed?
What is the trajectory of symptoms beyond 12 months, and does Long COVID ever fully resolve in the majority of affected individuals?